General Information of Drug (ID:
DR1191) |
Drug Name |
Olodaterol hydrochloride
|
Synonyms |
Olodaterol HCl; Olodaterol hydrochloride [usan]; BI 1744 CL; BI 1744 hydrochloride; BI-1744 HCl; Bi-1744-cl; OLODATEROL HYDROCHLORIDE; SCHEMBL560669; olodaterol-hydrochloride; 6-hydroxy-8-[(1R)-1-hydroxy-2-[[1-(4-methoxyphenyl)-2-methylpropan-2-yl]amino]ethyl]-4H-1,4-benzoxazin-3-one hydrochloride; 6-hydroxy-8-{(1r)-1-hydroxy-2-{[1-(4-methoxyphenyl)-2-methylpropan-2-yl]amino}ethyl}-4h-1,4-benzoxazin-3-one hydrochloride; 65R445W3V9; 869477-96-3; CHEBI:83309; UNII-65R445W3V9
|
Indication |
Chronic obstructive pulmonary disease
[ICD11: CA22]
|
Approved
|
[1]
|
Structure |
|
|
3D MOL is unavailable
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
422.9 |
Topological Polar Surface Area |
100 |
Heavy Atom Count |
29 |
Rotatable Bond Count |
7 |
Hydrogen Bond Donor Count |
5 |
Hydrogen Bond Acceptor Count |
6 |
Cross-matching ID |
- PubChem CID
- 11711522
- ChEBI ID
-
- CAS Number
-
- TTD Drug ID
- D04UTT
- Formula
- C21H27ClN2O5
- Canonical SMILES
- CC(C)(CC1=CC=C(C=C1)OC)NCC(C2=C3C(=CC(=C2)O)NC(=O)CO3)O.Cl
- InChI
- 1S/C21H26N2O5.ClH/c1-21(2,10-13-4-6-15(27-3)7-5-13)22-11-18(25)16-8-14(24)9-17-20(16)28-12-19(26)23-17;/h4-9,18,22,24-25H,10-12H2,1-3H3,(H,23,26);1H/t18-;/m0./s1
- InChIKey
- KCEHVJZZIGJAAW-FERBBOLQSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.